Read Time: 11 min read Key Takeaways Litigation status: Lawsuits involving Ozempic and other GLP-1 drugs have been grouped together in two separate multidistrict litigations (MDL), helping to expedite the legal process
Anti-platelet activity of a three-finger toxin (3FTx) from Indian monocled cobra ( Naja kaouthia ) venom
Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist that is used to treat obesity, type 2 diabetes, and weight-related health conditions such as metabolic dysfunction-associated steatohepatitis (MASH)
Managing These Gastrointestinal Side Effects Is Key to Making Sure You Get the Most Benefit From Ozempic, Whether Youre Using It for Blood Sugar Control or Weight Loss
Compounded drugs are prepared by a state-licensed compounding pharmacy partner and are permitted under federal law, however, they are not approved by the FDA and do not undergo safety, effectiveness, or manufacturing review